This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.
| Name | Shares | Options |
|---|---|---|
| HBM Healthcare Investments (Cayman) Ltd. | 1,747,680 | 0 |
| Loh Evan | 1,278,937 | 0 |
| BIGHAM MICHAEL | 1,231,827 | 0 |
| Lim Richard J. By Omega Fund III, L.P. | 1,187,365 | 0 |
| Lim Richard J. By Omega Fund IV, L.P. | 779,802 | 0 |
| Omega Fund III, L.P. | 779,802 | 0 |
| Woodrow Adam | 645,607 | 0 |
| Haskel William M. | 437,801 | 0 |
| Brenner Randall B. | 354,133 | 0 |
| Roumell Asset Management, LLC FN | 156,918 | 0 |
| Pagan Douglas W. | 134,057 | 0 |
| Stein Jeffrey | 10,125 | 7,000 |
| Radie Robert S | 6,750 | 7,000 |
| Dietz Thomas John | 375 | 7,000 |
| WORTZMAN MARILYN E | 18 | 0 |
| Ruegsegger Frederick J | 0 | 0 |
| Hoffmann Rolf K | 0 | 7,000 |
| Kjellson Nina S | 0 | 0 |
| HEMBERGER JUDITH A | 0 | 20,000 |
| OCLASSEN GLENN A | 0 | 0 |
| Stampacchia Otello By Funds | 0 | 0 |
| PATTERSON LEONE D | 0 | 0 |
| Roumell Asset Management, LLC | 0 | 0 |
| POWELL MICHAEL | 0 | 0 |
| InterWest Partners IX, LP | 0 | 0 |
| Franson Timothy R | 0 | 7,000 |
| Lim Richard J. By Omega Fund III, LP | 0 | 0 |
| WEBER ECKARD | 0 | 20,000 |
| Stampacchia Otello | 0 | 0 |
| SEARS LOWELL | 0 | 20,000 |
| ALBINI EDWARD C | 0 | 0 |
| Curd John G | 0 | 60,000 |
| LAPORTE KATHLEEN | 0 | 0 |
| Stampacchia Otello By Omega III | 0 | 0 |
| Boxmeyer Kathryn M. Jointly with spouse | 0 | 0 |
| AKKARAJU SRINIVAS | 0 | 0 |
| InterWest Management Partners IX, LLC | 0 | 0 |
| Baylor-Henry Minnie | 0 | 12,800 |
| Danish BioVenture General Partner ApS | 0 | 0 |
| BIGHAM MICHAEL By Abingworth Bioventures VI LP | 0 | 0 |
| Ehrlich Christopher B | 0 | 0 |
| 0 | 0 | |
| Boxmeyer Kathryn M. | 0 | 0 |
| Lim Richard J. By K/S Danish BioVenture | 0 | 0 |
| Nunn Jason Raleigh | 0 | 0 |
| KILEY THOMAS | 0 | 0 |
| Soloway Thomas P | 0 | 0 |
| Stampacchia Otello By Omega IV | 0 | 0 |
| Peterson Kristine | 0 | 7,000 |
| Danish BioVenture General Partner ApS By Danish BV | 0 | 0 |
| RAAB G KIRK | 0 | 45,000 |
| HEALY JAMES | 0 | 20,000 |
| Stampacchia Otello By Funds | 0 | 0 |
| Singh Nikhilesh N | 0 | 0 |
| LOAR MATTHEW M | 0 | 0 |
| Samuels Camille D | 0 | 20,000 |
| Kollins John A | 0 | 0 |
| Pepper Douglas A | 0 | 0 |
| WALKER JOHN PETER | 0 | 20,000 |
While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price
| Name | Shares | Price | Date |
|---|---|---|---|
| Woodrow Adam | 4,563 | 3.47 | 2022 Oct 28 |
| Loh Evan | 8,805 | 3.47 | 2022 Oct 28 |
| Haskel William M. | 4,382 | 3.47 | 2022 Oct 28 |
| Brenner Randall B. | 3,516 | 3.47 | 2022 Oct 28 |
| BIGHAM MICHAEL | 6,000 | 3.47 | 2022 Oct 28 |
| Loh Evan | 44,519 | 2.66 | 2022 Aug 09 |
| Brenner Randall B. | 19,608 | 2.66 | 2022 Aug 09 |
| Haskel William M. | 22,453 | 2.66 | 2022 Aug 09 |
| BIGHAM MICHAEL | 28,637 | 2.66 | 2022 Aug 09 |
Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.
| Name | Shares | Price | Date |
|---|